Download Poster (1.8 MB)


Background: Medical cannabis (MC), state-regulated cannabis programs accessible with a physician certification for a qualifying diagnosis, now exist in 47 states. Little attention has been paid to ensuring equitable access to such programs for the most vulnerable cancer patients.1 Estimates of cannabis use in cancer patients range from 30-40%2 yet access to MC is highly dependent on a number of variables including: geography, cost, availability of certifying providers, lack of provider education and a confusing array of state programs coupled with ongoing federal illegality. The historic criminalization of cannabis and the disproportionate impact on People of Color creates another significant barrier. Most state MC programs require patients to have a variety of skills and resources to participate. These may include internet access, email addresses, a credit or debit card, funds to pay for the certifying visit and product and the ability to access a proximal dispensary.

Publication Date



medical cannabis, cancer


Medicine and Health Sciences | Oncology


Presented at the 20th Annual American Psychosocial Oncology Society (APOS) Conference.

Development of an Equitable, Interprofessional Medical Cannabis Education, Certification and Research Program in an NCI-Designated Cancer Center

Included in

Oncology Commons